Mean platelet volume levels predict pulmonary artery hypertension in patients with atrial septal defect

Acta Cardiologica

Volumn 69, Issue 2, 2014, Pages 161-166

  Kaya, Mehmet Gungor ^a   Elcik, Deniz ^a   Akpek, Mahmut ^a   Kelesoglu, Saban ^a   Sahin, Omer ^a   Sarli, Bahadir ^a   Lam, Yat Yin ^b  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Atrial septal defect; Mean platelet volume; Pulmonary artery hypertension

Indexed keywords

CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTERY DIAMETER; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM SEPTUM DEFECT; HEART LEFT ATRIUM; HEART RIGHT ATRIUM; HUMAN; INFERIOR CAVA VEIN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PULMONARY HYPERTENSION; RECEIVER OPERATING CHARACTERISTIC; THROMBOCYTE VOLUME;

ADULT; CASE-CONTROL STUDIES; FEMALE; HEART SEPTAL DEFECTS, ATRIAL; HEART VENTRICLES; HUMANS; HYPERTENSION, PULMONARY; MALE; MEAN PLATELET VOLUME; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 84898451552     PISSN: 00015385     EISSN: 03737934     Source Type: Journal    
DOI: 10.1080/ac.69.2.3017297     Document Type: Article

References (27)

1. Kaya MG, Baykal A, Dogan A, Inanc T, Gunebakmaz O, Dogdu O, Uzum K, Eryol NK, Narin N. Intermediate-term effects of transcatheter secundum atrial septal defect closure on cardiac remodeling in children and adults. Pediatr Cardiol 2010; 31: 474-82.
2. Jacobs JP, Burke RP, Quintessanza JA, Mavroudis C. Congenital Heart Surgery Nomenclature and Database Project: atrial septal defect. Ann Thorac Surg 2000; 69(4Suppl): S18-24.
3. Gatzoulis MA, Redington AN, Somerville JS, Shore DF. Should atrial septal defects be closed in adults? Ann Thorac Surg 1996; 61: 657-9.
4. Perloff JK. Surgical closure of atrial septal defect in adults. N Engl J Med 1995; 333: 513-4.
5. Perros F, Dorfmuller P, Humbert M. Current insights on the pathogenesis of pulmonary arterial hypertension. Semin Respir Crit Care Med 2005; 26: 355-64.
6. Varol E, Uysal BA, Ozaydin M. Platelet Indices in Patients with Pulmonary Arterial Hypertension. Clin Appl Thromb Hemost 2011; 17: E171-4.
7. Park Y, Schoene N, Haris W. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets 2002; 13: 301-6.
8. Boos CJ, Lip GY. Assessment of mean platelet volume in coronary artery disease-what does it mean? Thromb Res 2007; 120: 11-3.
9. Martin JF, Trowbridge EA, Salmon GL, Plumb J. The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 1983; 32: 443-60.
10. Giles H, Smith REA, Martin JF. Platelet glycoprotein IIb-IIIa and size are increased in acute myocardial infarction. Eur J Clin Invest 1994; 24: 69-72.
11. Can MM, Tanboga IH, Demircan HC, Ozkan A, Koca F, Keleş N, Sonmez K, Kaymaz C, Serebruany V. Enhanced hemostatic indices in patients with pulmonary arterial hypertension: an observational study. Thromb Res 2010; 126: 280-2.
12. Sakamaki F, Kyotani S, Nagaya N, Sato N, Oya H, Satoh T, Nakanishi N. Increased plasma P-selectin and decreased thrombomodulin in pulmonary arterial hypertension were improved by continuous prostacyclin therapy. Circulation 2000; 102: 2720-5.
13. Nakonechnicov S, Gabbasov Z, Chazova I, Popov E, Belenkov Y. Platelet aggregation in patients with primary pulmonary hypertension. Blood Coagul Fibrinolysis 1996; 7: 225-7.
14. Pearlman AS, Borer JS, Clark CE. Abnormal right ventricular size and ventricular septal motion after atrial septal defect closure: etiology and functional significance. Am J Cardiol 1978: 41: 295-301.
15. Perloff JK. Ostium secundum atrial septal defect survival for 87 and 94 years. Am J Cardiol 1984; 53: 388-9.
16. Kaya MG, Ozdoǧru I, Baykan A, Doǧan A, Inanc T, Doǧdu O, Uzum K, Narin N, Topsakal R, Ergin A, Oǧuzhan A, Eryol NK. Transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder in adult patients: our first clinical experiences. Turk Kardiyol Dern Ars 2008; 36: 287-93 [article in Turkish].
17. Yarlioglues M, Kaya MG, Ardic I, Dogdu O, Kasapkara HA, Gunturk E, Akpek M, Kalay N, Dogan A, Ozdogru I, Oguzhan A. Relationship between mean platelet volume levels and subclinical target organ damage in newly diagnosed hypertensive patients. Blood Press 2011; 20: 92-7.
18. Kaya MG, Yarlioglues M, Gunebakmaz O, Gunturk E, Inanc T, Dogan A, Kalay N, Topsakal R. Platelet activation and inflammatory response in patients with non-dipper hypertension. Atherosclerosis 2010; 209: 278-82.
19. Kostrubiec N, Łabyk A, Pedowska-Włoszek J, Hrynkiewicz-Szymanska A, Pacho S, Jankowski K, Lichodziejewska B, Pruszczyk P. Mean platelet volume predicts early death in acute pulmonary embolism. Heart 2010; 96: 460-5.
20. Welsh CH, Hassell KL, Badesch DB, Kressin DC, Marlar RA. Coagulation and fibrinolytic profiles in patients with severe pulmonary hypertension. Chest 1996; 110: 710-7.
21. Bonderman D, Wilkens H, Wakounig S, Schafers HJ, Jansa P, Lindner J, Simkova I, Martischnig AM, Dudczak J, Sadushi R, Skoro-Sajer N, Klepetko W, Lang IM. Risk factors for chronic thromboembolicn pulmonary hypertension. Eur Respir J 2009; 33: 325-31.
22. Soon E, Holmes AM, Treacy CM, Doughty NJ, Southgate L, Machado RD, Trembath RC, Jennings S, Barker L, Nicklin P, Walker C, Budd DC, Pepke-Zaba J, Morrell NW. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation 2010; 122: 920-7.
23. Debili N, Masse JM, Katz A, Guichard J, Breton-Gorius J, Vainchenker W. Effects of the recombinant hematopoietic growth factors interleukin-3, interleukin-6, stem cell factor, and leukemia inhibitory factor on the megakaryocytic differentiation of CD34+ cells. Blood 1993; 82: 84-95.
24. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel NF, Rabinovitch M. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43(12 Suppl S): 13S-24S.
25. Budhiraja R, Tuder RM, Hassoun PM. Endothelial dysfunction in pulmonary hypertension. Circulation 2004; 109: 159-65.
26. Dastjerdi MS, Emami T, Najafian A, Amini M. Mean platelet volume measurement, EDTA or citrate? Hematology 2006; 11: 317-9.
27. Macey M, Azam U, McCarthy D, Webb L, Chapman ES, Okrongly D, Zelmanovic D, Newland A. Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology system. Clin Chem 2002; 48: 891-9.